awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
BJC.2014.519
BJC.2014.519
http://dx.doi.org/10.1038/BJC.2014.519
Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo.
P356
Q27853078-29AC7231-FC84-4C24-91AC-990F9969F6BC
P356
BJC.2014.519
http://dx.doi.org/10.1038/BJC.2014.519